Manila Bulletin
Two US firms offer COVID vaccines to PH
Two American biotech firms, Moderna and Arcturus, are willing to supply the Philippines between four to 25 million doses of their COVID-19 vaccines.
Philippine Ambassador to the US Jose Manuel Romualdez expressed hope that the Philippine government would consider these vaccines, with negotiations underway for Moderna's doses.
Moderna's vaccine has shown 94% effectiveness and is expected to receive emergency use authorization from US regulators soon.
Arcturus Therapeutics stated that its vaccine, ARCT021, which uses messenger RNA (mRNA) technology, would be available by the latter half of 2021.
Both companies utilize messenger RNA (mRNA) technology, a novel approach previously not used in human vaccines until the development of the Pfizer-BioNTech inoculation.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines has secured an assurance of 30 million doses of the Novavax COVID-19 vaccine from the Serum Institute of India.
+2
Read more →
The Philippines is in talks with China for its first COVID-19 vaccine, with an expected administration in March 2021.
Read more →
The Philippine government is seeking a $325 million (P15.6 billion) loan from the Asian Development Bank (ADB) to fund the procurement and logistical costs of COVID-19 vaccines.
+1
Read more →
Most procurement agreements for COVID-19 vaccines are expected to be signed by January 2021, according to vaccine czar Carlito Galvez Jr.
Read more →
President Rodrigo Duterte saw "no major lapse" in the country's negotiations with Pfizer for COVID-19 vaccines, with Malacañang stating that the ongoing talks mean it is not a major issue.
+1
Read more →